SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation

Experimental Hematology

Volumn 41, Issue 3, 2013, Pages 316-321

  Mohanty, Joy G ^a   Nagababu, Enika ^a   Friedman, Jeffrey S ^b   Rifkind, Joseph M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; HEMOGLOBIN; MANGANESE SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL GRANULE; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROCYTE DEFORMABILITY; FLUOROMETER; HEMATOPOIETIC CELL; MICROFLUIDICS; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RETICULOCYTE; SIDEROCYTIC GRANULE; SPECTROPHOTOMETRY;

ANIMALS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; ERYTHROID PRECURSOR CELLS; HEMATOPOIETIC STEM CELLS; HEME; HEMOGLOBINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; SPECTROMETRY, FLUORESCENCE; SUPEROXIDE DISMUTASE;

ANIMALIA; MUS;

EID: 84874977780     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.10.017     Document Type: Article

References (40)

1. Hebbel R.P. The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization. Semin Hematol 1990, 27:51-69.
2. Shinar E., Rachmilewitz E.A. Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 1990, 27:70-82.
3. Fibach E., Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med 2008, 8:609-619.
4. Winterbourn C.C. Oxidative denaturation in congenital hemolytic anemias: the unstable hemoglobins. Semin Hematol 1990, 27:41-50.
5. Martin F.M., Bydlon G., Friedman J.S. SOD2-deficiency sideroblastic anemia and red blood cell oxidative stress. Antioxid Redox Signal 2006, 8:1217-1225.
6. Cotter P.D., May A., Li L., et al. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis 2. Blood 1999, 93:1757-1769.
7. Martin F.M., Prchal J., Nieva J., et al. Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia. Br J Haematol 2008, 143:446-450.
8. Valentine J.S., Wertz D.L., Lyons T.J., Liou L.L., Goto J.J., Gralla E.B. The dark side of dioxygen biochemistry. Curr Opin Chem Biol 1998, 2:253-262.
9. McCord J.M., Keele B.B., Fridovich I. An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proc Natl Acad Sci U S A 1971, 68:1024-1027.
10. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J Biol Chem 1989, 264:7761-7764.
11. Srinivasan C., Liba A., Imlay J.A., Valentine J.S., Gralla E.B. Yeast lacking superoxide dismutase(s) show elevated levels of " free iron" as measured by whole cell electron paramagnetic resonance. J Biol Chem 2000, 275:29187-29192.
12. Li Y., Huang T.T., Carlson E.J., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995, 11:376-381.
13. Lebovitz R.M., Zhang H., Vogel H., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 1996, 93:9782-9787.
14. Melov S., Coskun P., Patel M., et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 1999, 96:846-851.
15. Williams M.D., Van R.H., Conrad C.C., Huang T.T., Epstein C.J., Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 1998, 273:28510-28515.
16. Van R.H., Williams M.D., Guo Z., et al. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am J Physiol Heart Circ Physiol 2001, 28:H1422-H1432.
17. Friedman J.S., Rebel V.I., Derby R., et al. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med 2001, 193:925-934.
18. Martin F.M., Bydlon G., Welsh M.L., Friedman J.S. A method for rapid mouse siderocyte enrichment. Exp Hematol 2005, 33:1493-1499.
19. Spolarics Z., Condon M.R., Siddiqi M., Machiedo G.W., Deitch E.A. Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice. Am J Physiol Heart Circ Physiol 2004, 286:H2118-H2126.
20. Samukawa K., Suzuki Y., Ohkubo N., Aoto M., Sakanaka M., Mitsuda N. Protective effect of ginsenosides Rg(2) and Rh(1) on oxidation-induced impairment of erythrocyte membrane properties. Biorheology 2008, 45:689-700.
21. Chan J.Y., Kwong M., Lo M., Emerson R., Kuypers F.A. Reduced oxidative-stress response in red blood cells from p45NFE2-deficient mice. Blood 2001, 97:2151-2158.
22. Aydogan S., Yapislar H., Artis S., Aydogan B. Impaired erythrocytes deformability in H(2)O(2)-induced oxidative stress: protective effect of L-carnosine. Clin Hemorheol Microcirc 2008, 39:93-98.
23. Nagababu E., Mohanty J.G., Bhamidipaty S., Ostera G.R., Rifkind J.M. Role of the membrane in the formation of heme degradation products in red blood cells. Life Sci 2010, 86:133-138.
24. Schroder E., Littlechild J.A., Lebedev A.A., Errington N., Vagin A.A., Isupov M.N. Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 A resolution. Structure 2000, 8:605-615.
25. Yang H.Y., Kwon J., Choi H.I., et al. In-depth analysis of cysteine oxidation by the RBC proteome: advantage of peroxiredoxin II knockout mice. Proteomics 2011, 12:101-112.
26. Shin S., Hou J.X., Suh J.S., Singh M. Validation and application of a microfluidic ektacytometer (RheoScan-D) in measuring erythrocyte deformability. Clin Hemorheol Microcirc 2007, 37:319-328.
27. Baskurt O.K., Boynard M., Cokelet G.C., et al. New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc 2009, 42:75-97.
28. Nagababu E., Fabry M.E., Nagel R.L., Rifkind J.M. Heme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C disease. Blood Cells Mol Dis 2008, 41:60-66.
29. Nagababu E., Rifkind J.M. Formation of fluorescent heme degradation products during the oxidation of hemoglobin by hydrogen peroxide. Biochem Biophys Res Commun 1998, 247:592-596.
30. Kendziorski C., Irizarry R.A., Chen K.S., Haag J.D., Gould M.N. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci U S A 2005, 102:4252-4257.
31. Peng X., Wood C.L., Blalock E.M., Chen K.C., Landfield P.W., Stromberg A.J. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 2003, 4:26-34.
32. Nagababu E., Rifkind J.M. Heme degradation by reactive oxygen species. Antioxid Redox Signal 2004, 6:967-978.
33. Nagababu E., Gulyani S., Earley C.J., Cutler R.G., Mattson M.P., Rifkind J.M. Iron-deficiency anaemia enhances red blood cell oxidative stress. Free Radic Res 2008, 42:824-829.
34. Walter P.B., Harmatz P., Vichinsky E. Iron metabolism and iron chelation in sickle cell disease. Acta Haematol 2009, 122:174-183.
35. Tanno T., Bhanu N.V., Oneal P.A., et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007, 13:1096-1101.
36. Kiefmann R., Rifkind J.M., Nagababu E., Bhattacharya J. Red blood cells induce hypoxic lung inflammation. Blood 2008, 111:5205-5214.
37. Egberts J., Hardeman M.R., Luykx L.M. Decreased deformability of donor red blood cells after intrauterine transfusion in the human fetus: possible reason for their reduced life span?. Transfusion 2004, 44:1231-1237.
38. Eschbach J.W., Funk D., Adamson J., Kuhn I., Scribner B.H., Finch C.A. Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 1967, 276:653-658.
39. Hsu C.Y., McCulloch C.E., Curhan G.C. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002, 13:504-510.
40. Prus E., Fibach E. Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells. Acta Haematol 2010, 123:14-20.